The Board will consider the following agenda items:
1. Fundraising Proposal: The board will consider raising funds in one or more tranches through various methods including:
- Issue of equity shares
- Any other instruments or eligible securities representing equity shares
- Convertible securities linked to equity shares
- Permissible modes or combination thereof including:
- Further public issue
- Right issues
- ADRs/GDRs/FCCBs
- Debt issue
- Preferential allotment
- Private placement
- Qualified institutions placement (QIP)
- Any other method permitted under applicable laws
2. Financial Results Approval: The board will consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June, 2026, along with the Limited Review Report.
3. Other Matters: The board may transact other incidental and ancillary matters as may be decided with the permission of the Chairperson.
Trading Window Closure
As previously intimated on 25th June, 2026, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended by SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, and in accordance with the Company's Code of Conduct:
- The Trading Window has been closed from 01st July, 2026
- The closure will remain in effect until the completion of 48 hours after the declaration of un-audited financial results for the quarter ended 30th June, 2026
- During this closed trading window period, Designated Persons and their immediate relatives are prohibited from trading in the Company's shares/securities